Results 51 to 60 of about 6,454 (214)

Hyperthyroidism incidence in a large population-based study in northeastern Italy

Endocrine Connections, 2023
Objective: An improvement in iodine status in Veneto Region has been documented in the last decade. We aimed at estimating the incidence of hyperthyroidism in the Veneto Region (Italy) over the period 2013–2022.
Simona Censi, Laura Salmaso, Filippo Ceccato, Jacopo Manso, Ugo Fedeli, Mario Saia, Caterina Mian   +6 more
doaj   +1 more source

Progress and Prospects of Rare Metal‐Based Electrochemiluminescence Sensors for Detection of Water Environmental Pollutants

Rare Metals, Volume 45, Issue 5, May 2026.
ABSTRACT Water pollution is becoming increasingly severe, posing a serious hazard to human health and ecological security. Therefore, it is necessary to develop rapid, sensitive, and universal analytical methods to detect residual pollutants in actual water.
Yi Xing, Ru Wu, Min Zhang, Faliang Cheng, Jun‐Jie Zhu   +4 more
wiley   +1 more source

Russian Association of Endocrinologists clinical practice guidelines for thyrotoxicosis diagnosis and treatment

Клиническая и экспериментальная тиреоидология, 2014
Clinical practice recommendations are dedicated to the management of patients with Graves' disease and multinodular toxic goiter.
Ekaterina Anatolyevna Troshina, Natalya Yuryevna Sviridenko, Vladimir Eduardovich Vanushko, Pavel Olegovich Rumyantsev, Valentin Viktorovich Fadeyev, Nina Aleksandrovna Petunina   +5 more
doaj   +1 more source

Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter [PDF]

, 2012
WOS: 000327389100021PubMed: 23211880Background and aims: The success of I-131 therapy in geriatric patients who were referred to an endocrinology clinic with toxic nodular goiter and who lived in iodine-deficiency regions was studied.
Demirin, Hilmi, Doğan, Ahmet Semih, Celbek, Gökhan, Aşık, Muhammed, Yıldırım, Mustafa, Aydın, Yusuf, Erkan, Melih Engin   +6 more
core   +1 more source

Advances in the Treatment of Sensorineural Hearing Loss: From Traditional Therapies to Stem Cell and Gene Therapies

Advanced Sensor Research, Volume 5, Issue 4, April 2026.
Sensorineural hearing loss (SNHL) occurs in 1.5 billion globally, primary driven by damage of cochlear hair cells and spiral ganglion neurons. This review systematically examines current therapeutic strategies for sensorineural hearing loss, including traditional drug and physical therapies as well as emerging stem cell and gene therapies, providing a ...
Ruirui Chen, Yang Zhang, Zhe Li, Renjie Chai   +3 more
wiley   +1 more source

Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease

Advanced Science, Volume 13, Issue 20, 9 April 2026.
This research identified cardiac amyloid pathology, neurotrophic factor depletion, and reduced myocardial nerve function in a transgenic model of cerebral amyloidosis (Tg2576), Aβ‐challenged cardiomyocytes, and in human AD heart tissue. These findings carry significant diagnostic and therapeutic implications, emphasizing the role of neuro‐signaling ...
Andrea Elia, Rebecca Parodi‐Rullan, Rafael Vazquez‐Torres, Ashley Carey, Huaqing Zhao, Sabzali Javadov, Silvia Fossati   +6 more
wiley   +1 more source

Familial risks for hospitalized Graves' disease and goiter [PDF]

, 2009
Objectives: Familial Clustering of a disease is an indicator of a possible heritable Cause. provided that environmental sharing can be excluded. Thus. data on familial risks are important For genetic Studies and for clinical genetic counseling.
Kari Hemminki, Sundquist, K,, Xinjun Li, Hemminki, Kari, Jianguang Ji, Li, Xinjun, Sundquist, Jan, Kristina Sundquist, Hemminki, K, Sundquist, Kristina, Ji, J, Sundquist, J, Shu, X, Jan Sundquist, Li, X, Xiaochen Shu, Ji, Jianguang, Shu, Xiaochen   +17 more
core   +2 more sources

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

British Journal of Clinical Pharmacology, Volume 92, Issue 4, Page 1023-1039, April 2026.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T. Muanda   +2 more
wiley   +1 more source

Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.

, 1998
Toxic multinodular goiter is a cause of nonautoimmune hyperthyroidism and is believed to differ in its nature and pathogenesis from toxic adenoma. Gain-of-function mutations of the TSH receptor gene have been identified as a cause of toxic adenoma.
Pinchera A, Cetani F, Vitti P., Agretti P, CHIOVATO, LUCA, Viacava P, Fiore E, Rocchi R, Miccoli P, Tonacchera M   +9 more
core   +1 more source

FEATURES OF THE COURSE AND PROGRESSION OF ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND NONCARDIAC PATHOLOGY

Сибирский научный медицинский журнал, 2019
Aim of the study – to investigate the features of the course of atrial fibrillation in patients with arterial hypertension and extracardiac pathology, affecting the progression of atrial fibrillation and the development of chronic heart failure (CHF ...
L. D. Khidirova, D. A. Yakhontov, S. A. Zenin   +2 more
doaj   +1 more source